Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 5, 2013, Pages 577-584

  Kalaitzakis, Evangelos ^a,b   Josefsson, Axel ^a   Castedal, Maria ^a   Henfridsson, Pia ^a   Bengtsson, Maria ^a   Andersson, Bengt ^c   Björnsson, Einar ^a,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Hepatic encephalopathy; Liver cirrhosis; Malnutrition; Renal function; Systemic inflammation

Indexed keywords

AMMONIA; GLUCOSE; HEMOGLOBIN; INSULIN; INTERLEUKIN 6; PRASTERONE; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMMONIA BLOOD LEVEL; ANEMIA; ARTICLE; CLINICAL ASSESSMENT; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISTRESS SYNDROME; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT FREE MASS; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HEPATIC ENCEPHALOPATHY; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTERNATIONAL NORMALIZED RATIO; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; LIVER FAILURE; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID FUNCTION TEST;

ABSORPTIOMETRY, PHOTON; ADULT; AMMONIA; ANEMIA; BODY MASS INDEX; CYTOKINES; FEMALE; GLOMERULAR FILTRATION RATE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THYROID HORMONES;

EID: 84876486583     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.777468     Document Type: Article

References (43)

1. Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology 2002;36:1163-71. (Pubitemid 35253432)
2. Olde Damink SW, Jalan R, Deutz NE, Redhead DN, Dejong CH, Hynd P, et al. The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis. Hepatology 2003;37: 1277-85. (Pubitemid 36667306)
3. Olde Damink SW, Dejong CH, Deutz NE, Redhead DN, Hayes PC, Soeters PB, et al. Kidney plays a major role in ammonia homeostasis after portasystemic shunting in patients with cirrhosis. Am J Physiol Gastrointest Liver Physiol 2006;291:G189-94. (Pubitemid 44024677)
4. Kalaitzakis E, Bjornsson E. Renal function and cognitive impairment in patients with liver cirrhosis. Scand J Gastro-enterol 2007;42:1238-44. (Pubitemid 47537086)
5. Guevara M, Baccaro ME, Rios J, Martin-Llahi M, Uriz J, Ruiz del Arbol L, et al. Risk factors for hepatic encephalop-athy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int 2010;30:1137-42.
6. Kalaitzakis E, Olsson R, Henfridsson P, Hugosson I, Bengtsson M, Jalan R, et al. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int 2007;27:1194-201. (Pubitemid 47543147)
7. Bessman SP, Bessman AN. The cerebral and peripheral uptake of ammonia in liver disease with an hypothesis for the mechanism of hepatic coma. J Clin Invest 1955;34:622-8.
8. Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, et al. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammo-nemia. J Clin Invest 1979;63:449-60. (Pubitemid 9130208)
9. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004;40:247-54. (Pubitemid 38115829)
10. Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalop-athy. Metab Brain Dis 2007;22:125-38. (Pubitemid 46354829)
11. Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol 2006; 101:1490-6. (Pubitemid 43980621)
12. Kalaitzakis E, Josefsson A, Bjornsson E. Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study. BMC Gastroenterol 2008;8:46.
13. Stewart CA, Enders FT, Mitchell MM, Felmlee-Devine D, Smith GE. The cognitive profile of depressed patients with cirrhosis. Prim Care Companion CNS Disord 2011;13.
14. Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett 2011;32:7-24.
15. Cheung K, Lee SS, Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol 2012;10:117-25.
16. Kalaitzakis E, Josefsson A, Castedal M, Henfridsson P, Bengtsson M, Hugosson I, et al. Factors related to fatigue in patients with cirrhosis before and after liver transplantation. Clin Gastroenterol Hepatol 2012;10:174-81; 81 e1.
17. Les I, Doval E, Flavia M, Jacas C, Cardenas G, Esteban R, et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol 2010;22:221-7.
18. Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med 2006;119:327-34.
19. Terekeci HM, Kucukardali Y, Onem Y, Erikci AA, Kucukardali B, Sahan B, et al. Relationship between anaemia and cognitive functions in elderly people. Eur J Intern Med 2010;21:87-90.
20. Borzio M, Caldara R, Borzio F, Piepoli V, Rampini P, Ferrari C. Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyr-oidism. Gut 1983;24:631-6. (Pubitemid 13066626)
21. Galbois A, Rudler M, Massard J, Fulla Y, Bennani A, Bonnefont-Rousselot D, et al. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred. J Hepatol 2010;52:839-45.
22. Franz C, Watson D, Longcope C. Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosis. Steroids 1979;34:563-73. (Pubitemid 10164646)
23. Zietz B, Lock G, Plach B, Drobnik W, Grossmann J, Scholmerich J, et al. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis. Eur J Gastroenterol Hepatol 2003;15:495-501. (Pubitemid 36571041)
24. Davis SR, Shah SM, McKenzie DP, Kulkarni J, Davison SL, Bell RJ. Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women. J Clin Endocrinol Metab 2008;93:801-8. (Pubitemid 351398556)
25. Chu LW, Tam S, Lee PW, Wong RL, Yik PY, Tsui W, et al. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men. Clin Endocrinol (Oxf) 2008;68:589-98. (Pubitemid 351388715)
26. Quinlan P, Nordlund A, Lind K, Gustafson D, Edman A, Wallin A. Thyroid hormones are associated with poorer cognition in mild cognitive impairment. Dement Geriatr Cogn Disord 2010;30:205-11.
27. Beluche I, Carriere I, Ritchie K, Ancelin ML. A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people. Psychol Med 2010;40: 1039-49.
28. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17:2034-47. (Pubitemid 44036188)
29. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-21. (Pubitemid 34183979)
30. Weissenborn K, Ruckert N, Hecker H, Manns MP. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 1998;28:646-53. (Pubitemid 28168003)
31. Kyle UG, Piccoli A, Pichard C. Body composition measurements: interpretation finally made easy for clinical use. Curr Opin Clin Nutr Metab Care 2003;6:387-93. (Pubitemid 40684589)
32. Coin A, Sergi G, Minicuci N, Giannini S, Barbiero E, Manzato E, et al. Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20-80 year-old Italian population. Clin Nutr 2008;27:87-94.
33. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. (Pubitemid 13098606)
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19. (Pubitemid 15018832)
35. Radikova Z, Koska J, Huckova M, Ksinantova L, Imrich R, Vigas M, et al. Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes 2006;114:249-56. (Pubitemid 44065178)
36. Hospital SU. Analyslistan. Gothenburg: Sahlgrenska University Hospital; 2010.
37. Butterworth RF. Hepatic encephalopathy: a neuropsychiatric disorder involving multiple neurotransmitter systems. Curr Opin Neurol 2000;13:721-7. (Pubitemid 32002658)
38. Mpabanzi L, Deutz N, Hayes PC, Dejong CH, Olde Damink SW, Jalan R. Overnight glucose infusion suppresses renal ammoniagenesis and reduces hyperammonaemia induced by a simulated bleed in cirrhotic patients. Aliment Pharmacol Ther 2012;35:8.921-8.
39. Huisman EJ, Trip EJ, Siersema PD, van Hoek B, van Erpecum KJ. Protein energy malnutrition predicts complications in liver cirrhosis. Eur J Gastroenterol Hepatol 2011;23: 982-9.
40. Hori T, Murawaki Y, Hirayama C. Hypogonadism in liver cirrhosis: implication in altered amino acid metabolism in muscle. Biochem Med Metab Biol 1988;39:168-75.
41. Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahe-patic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol 2008;103:2738-46.
42. Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, et al. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol 2009;7:689-95.
43. Morgan MY, Madden AM, Jennings G, Elia M, Fuller NJ. Two-component models are of limited value for the assessment of body composition in patients with cirrhosis. Am J Clin Nutr 2006;84:1151-62. (Pubitemid 44730387)